Sotera Health's stock presents a valuation conundrum, with discounted cash flow analysis suggesting a 37% upside while its sky-high P/E ratio signals overvaluation. As investors reassess biotech and pharmaceutical services firms, the debate intensifies around SHC's true worth.
At the annual J.P. Morgan Healthcare Conference, industry leaders grappled with a transformative agenda: navigating a looming patent cliff, geopolitical shifts, and a recalibrated M&A landscape, all while betting big on AI and obesity therapeutics.
Newly released body camera footage shows the moments leading to the police shooting of a 22-year-old man experiencing a mental health crisis in his Queens home. As the district attorney considers charges, Mayor Zohran Mamdani urges a focus on treatment, reigniting debate over emergency response protocols.
As the healthcare sector outpaces the broader market, investors are searching for sustainable winners. We analyze two companies with innovative models in cardiac care and senior health, while flagging one stock where the risks may outweigh the rewards.
GE HealthCare Technologies posted better-than-expected fourth-quarter results, driven by robust demand in pharmaceutical diagnostics and momentum from new product rollouts. The company's focus on expanding its service-based revenue streams is central to its growth outlook.
Industrial manufacturer IDEX surpassed Wall Street's revenue and profit forecasts for the fourth quarter, driven by robust demand in its Health, Science & Technology unit and key investments in data center infrastructure.
OSI Systems reported a quarter defined by strength in its security and optoelectronics businesses, which helped counterbalance persistent softness in healthcare. While delayed government bookings impacted timing, management expressed confidence in the underlying demand pipeline.
Siemens Healthineers reported a resilient start to fiscal 2026, with strong performance in its imaging and precision therapy divisions offsetting a significant downturn in its diagnostics business in China, prompting a strategic reassessment of its operations in the key Asian market.
IDEX Corporation capped off fiscal 2025 with stronger-than-anticipated fourth-quarter results, propelled by a record-setting order surge in its Health & Science Technologies unit linked to data center and AI infrastructure. While management expressed confidence in its strategic evolution, it offered a measured outlook for the coming year amid a mixed industrial landscape.
Following a challenging third quarter and the suspension of a key carrier partnership, GoHealth's valuation model holds steady, but revenue forecasts are trimmed. Analysts are divided on whether stringent cost controls can pave the way for a sustainable recovery.
UK-based Futura Medical secures a key US patent allowance, safeguarding its erectile dysfunction gel Eroxon and an investigational women's sexual health treatment until 2040, while triggering a $2.5 million milestone payment from partner Haleon.
After delivering staggering multi-year returns of over 225%, Welltower (WELL) finds itself at a crossroads. Our analysis delves into whether the current share price reflects its intrinsic value or signals a potential bubble in the senior housing and healthcare real estate sector.
Catapult Sports unveils its next-generation Perch P2 training system, expanding its focus from on-field performance tracking to integrated gym and rehabilitation workflows, as the company aims to build a comprehensive athlete health ecosystem.
The telehealth company's new lab testing service is seen as a strategic move to evolve beyond online pharmacy, aiming to create a data-driven, end-to-end health platform. While shares have faced pressure, some analysts see long-term potential in its personalized care model.
Centene Corporation is set to report fourth-quarter earnings before the bell Friday. Investors will scrutinize whether the Medicaid-focused managed care giant can maintain its impressive track record of topping revenue estimates, even as the broader health insurance sector faces headwinds.
GE HealthCare Technologies' shares have faced recent pressure, lagging behind broader market and industry peers. A deep dive into valuation metrics, including discounted cash flow and P/E analysis, suggests the stock may be significantly undervalued. We examine the numbers and the narratives shaping investor sentiment.
UnitedHealth Group faces a multi-front challenge as a Department of Justice investigation into Medicare billing coincides with proposed payment changes and new transparency rules for its pharmacy unit, testing the resilience of its integrated business model.
For retirees considering a move, climate and cost of living often dominate the conversation. But experts warn that overlooking the quality and accessibility of local healthcare systems could be a costly mistake with long-term consequences for well-being and finances.
Oscar Health's fair value estimate has been revised upward to $15.78, reflecting a measured recalibration of expectations amid a split analyst outlook. While some point to improved execution in core markets, others warn of persistent risks to profitability.
An investigation reveals the Baltimore City Health Department spent public funds on consultants who advised separate 'White caucus' and 'people of color caucus' meetings, igniting a debate on the methods and ethics of public sector DEI initiatives.
